Cargando…

Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice

We investigated the biodistribution, radiolocalization, and radioimmunotherapeutic potential of (131)I‐labeled Nd2 in athymic nude mice bearing human pancreatic carcinoma xenografts. (131)I‐Nd2 was accumulated at high levels in the tumor, in contrast to blood, liver, spleen, and other normal organs....

Descripción completa

Detalles Bibliográficos
Autores principales:	Inui, Akimasa, Chung, Yong‐Suk, Sawada, Tetsuji, Kondo, Yasuyuki, Ho, Jenny J. L., Kim, Young‐S., Sowa, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921207/ https://www.ncbi.nlm.nih.gov/pubmed/8878462 http://dx.doi.org/10.1111/j.1349-7006.1996.tb02129.x

Ejemplares similares

Radioimmunodetection with (111)In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer
por: Chung, Yong‐Suk, et al.
Publicado: (1997)

Intratumoral Injection of an Adriamycin Immunoconjugate against Human Pancreatic Cancer Xenografts
por: Kondo, Yasuyuki, et al.
Publicado: (1995)

Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
por: Saiful Alam, A. F.
Publicado: (1991)

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
por: Gerretsen, M., et al.
Publicado: (1992)

Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
por: Yoneda, S., et al.
Publicado: (1988)

Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
por: Lin, Ruoting, et al.
Publicado: (2021)

Radioimmunotherapy of pancreatic cancer xenografts in nude mice using (90)Y-labeled anti-α(6)β(4) integrin antibody
por: Aung, Winn, et al.
Publicado: (2016)

Rhenium‐186‐mercaptoacetyltriglycine‐labeled Monoclonal Antibody for Radioimmunotherapy: In vitro Assessment, in vivo Kinetics and Dosimetry in Tumor‐bearing Nude Mice
por: Kinuya, Seigo, et al.
Publicado: (1998)

Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
por: Zhang, Linhan, et al.
Publicado: (2022)

Fractionated (131)I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice
por: Violet, J A, et al.
Publicado: (2008)

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).
por: Antoniw, P., et al.
Publicado: (1996)

Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by (111)In‐labeled Chimeric Monoclonal Antibody Nd2
por: Sawada, Tetsuji, et al.
Publicado: (1999)

Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin’s lymphoma
por: Andemariam, Biree, et al.
Publicado: (2007)

Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
por: Pedley, R. B., et al.
Publicado: (1993)

Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy
por: Uccelli, Licia, et al.
Publicado: (2017)

Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.
por: Vaidyanathan, G., et al.
Publicado: (1996)

Flow Cytometric Bromodeoxyuridine/DNA Analysis of Hyperthermia and/or Adriamycin for Human Pancreatic Adenocarcinoma Cell Line Capan‐2
por: Nakata, Bunzo, et al.
Publicado: (1992)

A (90)Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
por: Fujiwara, Kentaro, et al.
Publicado: (2014)

Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice
por: Weng, Dinghu, et al.
Publicado: (2017)

Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
por: Bosslet, K., et al.
Publicado: (1991)

Enhanced tumor inhibiting effect of 131I-BDI-1-based radioimmunotherapy and cytosine deaminase gene therapy modulated by a radio-sensitive promoter in nude mice bearing bladder cancer
por: Hao, Pan, et al.
Publicado: (2022)

Intraperitoneal Alpha-Radioimmunotherapy of Advanced Ovarian Cancer in Nude Mice Using Different High Specific Activities
por: Elgqvist, Jorgen, et al.
Publicado: (2010)

Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma
por: Ludwig, Andrew D., et al.
Publicado: (2019)

Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
por: Burdick, Michael J, et al.
Publicado: (2009)

Standard Operating Procedure for In-house Preparation of (131)I-rituximab for Radioimmunotherapy of Non-Hodgkin's Lymphoma
por: Pickford, Matthew D., et al.
Publicado: (2012)

Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer
por: Nishihara, Tamahiro, et al.
Publicado: (2000)

Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
por: Turner, J. H., et al.
Publicado: (1998)

Enhanced Efficacy of Radioimmunotherapy Combined with Systemic Chemotherapy and Local Hyperthermia in Xenograft Model
por: Kinuya, Seigo, et al.
Publicado: (2000)

Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
por: Allum, W. H., et al.
Publicado: (1986)

Reliable Establishment of Human Sarcoma Xenografts in the Nude Rat
por: Tinkey, Peggy T., et al.
Publicado: (1999)

The development of xenograft glioblastoma implants in nude mice brain
por: Behar, FM, et al.
Publicado: (2008)

Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma
por: Calais, Phillipe J., et al.
Publicado: (2012)

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
por: Kievit, E., et al.
Publicado: (1996)

Growth of human digestive-tumour xenografts in athymic nude rats.
por: Davies, G., et al.
Publicado: (1981)

BCG treatment of human tumour xenografts in athymic nude mice.
por: Pimm, M. V., et al.
Publicado: (1978)

Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse.
por: Bernsen, H. J., et al.
Publicado: (1995)

Testosterone inhibits the growth of prostate cancer xenografts in nude mice
por: Song, Weitao, et al.
Publicado: (2017)

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
por: Dillman, R. O.
Publicado: (2006)

Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody.
por: Smith, A., et al.
Publicado: (1991)

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
por: Lane, D. M., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_g9300ml027uoi54eu9003pjsn3